Literature DB >> 2962843

In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.

S Breyer1, A Georgopoulos, W Graninger.   

Abstract

In vitro activities of teicoplanin were compared with those of ampicillin, imipenem, rifampicin, coumermycin and vancomycin against clinical isolates of Streptococcus faecalis (n = 100) and Streptococcus faecium (n = 30). Against Str. faecalis, ampicillin and imipenem had an MIC90 and MBC90 of 3.9 micrograms/ml. Coumermycin and rifampicin had poor bactericidal activity with MBC90 values of 31.2 and 62.5 micrograms/ml. Teicoplanin was extremely active with an MIC90 of 0.95 microgram/ml and an MBC90 of 1.86 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962843

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  2 in total

Review 1.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.

Authors:  P Kempf; H Pompetzki; A Oppermann; R Wittenberger; J Siebert; J J Fell; H A Dieterich
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.